PROK
ProKidney Corp.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$552.59M
P/E Ratio
—
EPS
$-0.52
Beta
1.86
52W High
$5.95
52W Low
$0.54
50-Day MA
$2.05
200-Day MA
$2.42
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ProKidney Corp.
ProKidney Corporation. The company is headquartered in Winston-Salem, North Carolina.
Fundamentals
| Revenue (TTM) | 893,000 |
| Gross Profit (TTM) | 893,000 |
| EBITDA | $-158.43M |
| Operating Margin | -20306.00% |
| Return on Equity | -43.20% |
| Return on Assets | -26.60% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $-7.13 |
| Price-to-Book | 97.15 |
| Price-to-Sales (TTM) | 618.80 |
| EV/Revenue | 10.61 |
| EV/EBITDA | 2.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 196.10% |
| Shares Outstanding | $141.99M |
| Float | $93.69M |
| % Insiders | 24.39% |
| % Institutions | 34.44% |
Historical Volatility
HV 10-Day
78.65%
HV 20-Day
75.67%
HV 30-Day
75.98%
HV 60-Day
74.71%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($6.25 target)
4
Buy2
Hold1
Strong SellData last updated: 4/29/2026